Parkwood LLC’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-68,314
| Closed | -$73K | – | 166 |
|
|
2023
Q3 | $73K | Hold |
68,314
| – | – | 0.01% | 128 |
|
|
2023
Q2 | $177K | Hold |
68,314
| – | – | 0.03% | 121 |
|
|
2023
Q1 | $279K | Hold |
68,314
| – | – | 0.04% | 128 |
|
|
2022
Q4 | $343K | Buy |
68,314
+24,000
| +54% | +$121K | 0.05% | 122 |
|
|
2022
Q3 | $580K | Buy |
+44,314
| New | +$580K | 0.09% | 107 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$1.05M | – | 140 |
|
|
2021
Q3 | $1.05M | Buy |
+50,000
| New | +$1.05M | 0.13% | 91 |
|